License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. We report a case of a 41-year-old male who presented with tachycardia and swelling of his left arm six weeks after he started antituberculosis treatment and stopped his rheumatoid arthritis infliximab treatment. Hewas diagnosedwith pulmonary embolism by chest CT and initially treated with warfarin, which interacted with his antituberculosis treatment.This presentation of deep vein thrombosis and pulmonary embolism as part of immune reconstitution inflammatory syndrome has not been previously reported for infliximab treated patients. 1
Infliximab therapy is associated with higher rates of active tuberculosis (TB), particularly extrapu...
Non-steroidal anti-inflammatory drugs have been associated with an increased risk of venous thrombo...
(See the editorial commentary by Keane on pages 300–2) Infliximab, a tumor necrosis factor (TNF) ant...
We report a case of a 41-year-old male who presented with tachycardia and swelling of his left arm s...
Anti-TNF-α agents have been used for the treatment of several autoimmune diseases, including rheumat...
Tumor necrosis factor (TNF)-alpha inhibitors play an important role in the treatment of immun-mediat...
The use of Infliximab in the treatment of patients with rheumatoid diseases unresponsive to conventi...
SummaryThe introduction of infliximab, an anti-TNF-α agent, in the treatment of rheumatic diseases h...
AbstractTumor necrosis factor (TNF)-alpha inhibitors play an important role in the treatment of immu...
The use of Infliximab in the treatment of patients with rheumatoid diseases unresponsive to conventi...
Abstract Introduction The use of the drug infliximab for the treatment of patients with Crohn's dise...
peer reviewedInfliximab is an IgG1κ monoclonal antibody against tumor necrosis factor-α (anti-TNFα) ...
A man in his sixth decade with Crohn’s colitis and who had been taking infliximab for 18 months pres...
Pulmonary embolism is a complication of pulmonary tuberculosis that has received little emphasis in ...
A 39-year-old Indian man was diagnosed with ulcerative colitis on colonic biopsy and started on mesa...
Infliximab therapy is associated with higher rates of active tuberculosis (TB), particularly extrapu...
Non-steroidal anti-inflammatory drugs have been associated with an increased risk of venous thrombo...
(See the editorial commentary by Keane on pages 300–2) Infliximab, a tumor necrosis factor (TNF) ant...
We report a case of a 41-year-old male who presented with tachycardia and swelling of his left arm s...
Anti-TNF-α agents have been used for the treatment of several autoimmune diseases, including rheumat...
Tumor necrosis factor (TNF)-alpha inhibitors play an important role in the treatment of immun-mediat...
The use of Infliximab in the treatment of patients with rheumatoid diseases unresponsive to conventi...
SummaryThe introduction of infliximab, an anti-TNF-α agent, in the treatment of rheumatic diseases h...
AbstractTumor necrosis factor (TNF)-alpha inhibitors play an important role in the treatment of immu...
The use of Infliximab in the treatment of patients with rheumatoid diseases unresponsive to conventi...
Abstract Introduction The use of the drug infliximab for the treatment of patients with Crohn's dise...
peer reviewedInfliximab is an IgG1κ monoclonal antibody against tumor necrosis factor-α (anti-TNFα) ...
A man in his sixth decade with Crohn’s colitis and who had been taking infliximab for 18 months pres...
Pulmonary embolism is a complication of pulmonary tuberculosis that has received little emphasis in ...
A 39-year-old Indian man was diagnosed with ulcerative colitis on colonic biopsy and started on mesa...
Infliximab therapy is associated with higher rates of active tuberculosis (TB), particularly extrapu...
Non-steroidal anti-inflammatory drugs have been associated with an increased risk of venous thrombo...
(See the editorial commentary by Keane on pages 300–2) Infliximab, a tumor necrosis factor (TNF) ant...